Combined prevention of infectious complications of minimally invasive procedures in urology

Мұқаба
  • Авторлар: Esipov A.1,2, Martov A.3,4,5, Kochetov A.6,7, Musailov V.1,2, Ragimov I.8
  • Мекемелер:
    1. National Medical Research Center for High Medical Technologies – Central Military Clinical Hospital named after A.A. Vishnevsky of the Ministry of Defense of Russian Federation
    2. S.M. Kirov Military Medical Academy of the Ministry of Defense of Russian Federation
    3. A.I. Burnazyan SRC FMBC, FMBA of Russia
    4. City Clinical Hospital named after D.D. Pletnev of the Moscow Health Department
    5. Lomonosov Moscow State University
    6. National Medical Research Center for High Medical Technologies – Central Military Clinical Hospital named after A.A. Vishnevsky
    7. Russian Biotechnological University
    8. Branch No. 3 of the National Medical Research Center for High Medical Technologies – Central Military Clinical Hospital named after A.A. Vishnevsky
  • Шығарылым: № 4 (2024)
  • Беттер: 110-115
  • Бөлім: Literature reviews
  • URL: https://journals.rcsi.science/1728-2985/article/view/264915
  • DOI: https://doi.org/10.18565/urology.2024.4.110-115
  • ID: 264915

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The available literature data on the prevention of infectious and inflammatory complications after minimally invasive urological procedures based on current knowledge about urobiome as the main point of application of preventive measures are summarized in the article. The main risk factors for the occurrence of inflammatory complications at all stages of the perioperative process are analyzed. The role of antibacterial prophylaxis is emphasized, and its features and the importance of finding ways to overcome one of the main problems of modern medicine, which is antibiotic resistance, are discussed.

Толық мәтін

##article.viewOnOriginalSite##

Авторлар туралы

A. Esipov

National Medical Research Center for High Medical Technologies – Central Military Clinical Hospital named after A.A. Vishnevsky of the Ministry of Defense of Russian Federation; S.M. Kirov Military Medical Academy of the Ministry of Defense of Russian Federation

Хат алмасуға жауапты Автор.
Email: alieksandr.iesipov@mail.ru
ORCID iD: 0000-0001-8239-539X

MD, Associate Professor, Major General of the Medical Service, Honored Doctor of the Russian Federation, Head; Professor of the Department of Surgery with a Course of Oncology and Radiation Diagnostics

Ресей, Krasnogorsk; Moscow

A. Martov

A.I. Burnazyan SRC FMBC, FMBA of Russia; City Clinical Hospital named after D.D. Pletnev of the Moscow Health Department; Lomonosov Moscow State University

Email: martovalex@mail.ru
ORCID iD: 0000-0001-6324-6110

Corresponding Member of RAS, PhD, MD, Professor, Head of the Department of Urology and Andrology; Head of the Department of Urology; Professor of the Department of Urology

Ресей, Moscow; Moscow; Moscow

A. Kochetov

National Medical Research Center for High Medical Technologies – Central Military Clinical Hospital named after A.A. Vishnevsky; Russian Biotechnological University

Email: dr.aleksandr68@yandex.ru
ORCID iD: 0000-0003-3631-598X

PhD, MD, Head of the Urologic Center; Head of the Department of Urology

Ресей, Krasnogorsk; Moscow

V. Musailov

National Medical Research Center for High Medical Technologies – Central Military Clinical Hospital named after A.A. Vishnevsky of the Ministry of Defense of Russian Federation; S.M. Kirov Military Medical Academy of the Ministry of Defense of Russian Federation

Email: musailove@mail.ru
ORCID iD: 0000-0002-0168-0939

MD, Lieutenant Colonel of the Medical Service, Head of the Surgical Department with Operating Units; Lecturer of the Department of Surgery of Emergency Conditions

Ресей, Krasnogorsk; Moscow

I. Ragimov

Branch No. 3 of the National Medical Research Center for High Medical Technologies – Central Military Clinical Hospital named after A.A. Vishnevsky

Email: uromail@mail.ru
ORCID iD: 0000-0002-7679-4199

PhD, Lieutenant Colonel of the Medical Service, Head of the Urology Department

Ресей, Odintsovo

Әдебиет тізімі

  1. Perepanova T.S., Merinov D.S., Kazachenko A.V., Khazan P.L., et al. Prevention of infectious and inflammatory complications after percutaneous nephrolithotomy. Urology. 2020;3:26–34. Russian (Перепанова Т.С., Меринов Д.С., Казаченко А.В., Хазан П.Л., и др. Профилактика инфекционно-воспалительных осложнений после перкутанной нефролитотрипсии. Урология. 2020;3:26–34).
  2. Villa L., Dioni P., Candela L., Ventimiglia E., De Angelis M., et al. Understanding the role of ureteral access sheath in preventing post-operative infectious complications in stone patients treated with ureteroscopy and Ho:YAG laser lithotripsy. J Clin.Med. 2023;12(4):1457. doi: 10.3390/jcm12041457.
  3. Lightner D.J., Wymer K., Sanchez J., Kavoussi L. Best practice statement on urologic procedures and antimicrobial prophylaxis. J Urol. 2020;203:351–356. doi: 10.1097/JU.0000000000000509.
  4. Esipov A.V., Alechnovich A.V., Kislenko A.M., Markevich P.S. et al. Bacteriophages under conditions of absorption of antibiotic resistance. Hospital medicine: science and practice. 2018;1(2):39–42. Russian (Есипов А.В., Алехнович А.В., Кисленко А.М., Маркевич П.С. и др. Бактериофаги в условиях поглощающей антибиотикорезистентности. Госпитальная медицина: наука и практика. 2018;1(2):39–42).
  5. Esipov A.V., Markevich P.S., Alekhnovich A.V., Aleshkin A.V., Kiseleva I.A., Musailov V.A. Antibiotic resistance of microorganisms and possible ways to overcome it (literature review)). Voenno-medicinskij žurnal. 2023;6:39–44. Russian (Есипов А.В., Маркевич П.С., Алехнович А.В., Алешкин А.В., Киселева И.А., Мусаилов В.А. Антибиотикорезистентность микроорганизмов и возможные пути ее преодоления (обзор литературы). Военно-медицинский журнал. 2023;6:39–44).
  6. Zhou G., Zhou Y., Chen R., Wang D., Zhou S., et al. The influencing factors of infectious complications after percutaneous nephrolithotomy: a systematic review and meta-analysis. Urolithiasis. 2023;51(1). doi: 10.1007/s00240-022-01376-5.
  7. Sleator R.D. The human superorganism - of microbes and men. Med. Hypotheses. 2010;74(2):214–215. doi: 10.1016/j.mehy.2009.08.047.
  8. Jones J., Murphy C.P., Sleator R.D., Culligan E.P. The urobiome, urinary tract infections, and the need for alternative therapeutics. Microb. Pathog. 2021;110:105295. doi: 10.1016/j.micpath.2021.105295.
  9. Kenneally C., Murphy С.P., Sleator R.D., Culligan E.P. The urinary microbiome and biological therapeutics: Novel therapies for urinary tract infections. Microbiol Res. 2022;259:127010. doi: 10.1016/j.micres.2022.127010.
  10. Grabe M.J., Lundström K.-J. Tailored perioperative antimicrobial prophylaxis in urological surgery: myth or reality? Current Opinion in Urology. 2017;27(2):112–119. doi: 10.1097/MOU.0000000000000363.
  11. European Association of Urology. Guidelines on Urological infections (version 2023). Available on www.uroweb.org/guidelines/. http://uroweb.org/wp-content/uploads/EAU-Guidelines-Urological-Infections-2023.pdf (07.02.2024).
  12. Global Guidelines for the Prevention of Surgical Site Infection. World Health Organization; 2018. https://www.who.int/publications/i/item/9789241550475 (07.02.2024).
  13. Urolithiasis (Clinical recommendations). Russian Society of Urologists, 2023 (at least once every 3 years). (Revised. There is a public discussion) https://ooorou.ru/library/russian-guidlines/(02/07/2024). Russian (Мочекаменная болезнь (Клинические рекомендации). Российское общество урологов, 2023 (не реже 1 раза в 3 года). (Пересмотрены. Идет общественное обсуждение) https://ooorou.ru/library/russian-guidlines/(07.02.2024)).
  14. Protoshchak V.V., Paronnikov M.V., Orlov D.N., Kochetov A.G., etc. Medical and statistical characteristics of the incidence of urolithiasis in the Armed Forces. Voenno-medicinskij žurnal. 2020;11:11–18. Russian (Протощак В.В., Паронников М.В., Орлов Д.Н., Кочетов А.Г. и др. Медико-статистическая характеристика заболеваемости мочекаменной болезнью в Вооруженных Силах. Военно-медицинский журнал. 2020;11:11–18).
  15. Martov A., Gravas S., Etemadian M., et al. Postoperative infection rates in patients with a negative baseline urine culture undergoing ureteroscopic stone removal: a matched case-control analysis on antibiotic prophylaxis from the CROES URS global study. J. Endourol. 2015;29:171–180.
  16. Puia D., Gheorghincă S., Radavoi G., Jinga V., Pricop C. Can we identify the risk factors for SIRS/sepsis after percutaneous nephrolithotomy? A meta-analysis and literature review. Exp. Ther. Med., 2023;25(3):110. doi: 10.3892/etm.2023.11809.
  17. Troxel S.A., Low R.K. Renal intrapelvic pressure during percutaneous nephrolithotomy and its correlation with the development of postoperative fever. J. Urol. 2002;168:1348–1351. doi: 10.1016/S0022-5347(05)64446-1.
  18. Bilsen M., Jongeneel R., Schneeberger C., Platteel T., van Nieuwkoop C., Mody L., Caterino J., Geerlings S., Köves B., Wagenlehner F., Conroy S., Visser L., Lambregts M. Definitions of urinary tract infection in current research: a systematic review. Open Forum Infect. Dis. 2023;10(7): ofad332. doi: 10.1093/ofid/ofad332.
  19. Danilovic A., Talizin T.B., Torricelli F.C.M., Marchini G.S., Batagello C., Vicentini F.C., Nahas W.C., Mazzucchi E. One-week pre-operative oral antibiotics for percutaneous nephrolithotomy reduce risk of infection: a systematic review and meta-analysis. Int Braz J Urol. 2023;49(2):184–193. doi: 10.1590/S1677-5538.IBJU.2022.0544.
  20. Gu J., Liu J., Hong Y., Feng Y., Huang X. Nomogram for predicting risk factor of urosepsis in patients with diabetes after percutaneous nephrolithotomy. BMC Anesthesiol. 2022;22:87. doi: 10.1186/s12871-022-01629-1.
  21. Yang С., Wei H., Zhan H. et al. Effect of preoperative prophylactic antibiotic use on postoperative infection after percutaneous nephrolithotomy in patients with negative urine culture: a single-center randomized controlled trial. World J Urol. 2023;41(12):3687–3693. doi: 10.1007/s00345-023-04623-5.
  22. Esipov A.V., Alekhnovich A.V., Markevich P.S., Kislenko A.M., et al. The role of biofilms in the pathogenesis of catheter-associated urinary tract infections. Hospital medicine: science and practice. 2021;4(1):26–30. Russian (Есипов А.В., Алехнович А.В., Маркевич П.С., Кисленко А.М., и др. Роль биоплёнок в патогенезе катетер-ассоциированных инфекций мочевыводящих путей. Госпитальная медицина: наука и практика. 2021;4(1):26–30).
  23. Nevo A., Mano R., Baniel J., Lifshitz D.A. Ureteric stent dwelling time: a risk factor for post-ureteroscopy sepsis. BJU Int. 2017. https://doi.org/10.1111/bju.13796
  24. Desai M., Jain P., Ganpule A., Sabnis R., Patel S., Shrivastav P. Developments in technique and technology: The effect on the results of percutaneous nephrolithotomy for staghorn calculi. BJU Int. 2009;104:542–548.
  25. Bapir R., Hassan K., Eliwa A. et al. Infectious complications of endourological treatment of kidney stones: A meta-analysis of randomized clinical trials. Archivio Italiano di Urologia e Andrologia. 2022;94:1. doi: 10.4081/aiua.2022.1.97.
  26. Perepanova T.S., Golovanov S.A., Merinov D.S., Arustamov L.D., et al. Metaphylaxis of infectious kidney stones after percutaneous nephrolithotripsy. Experimental and clinical urology. 2016;4:96–99. Russian (Перепанова Т.С., Голованов С.А., Меринов Д.С., Арустамов Л.Д., и др. Метафилактика инфекционных камней почек после перкутанной нефролитотрипсии. Экспериментальная и клиническая урология. 2016;4:96–99).
  27. Gvasalia B.R., Kochetov A.G. Comparative analysis of the use of silicone urethral catheters with and without silver coating in the prevention of nosocomial urinary tract infections. Andrology and genital surgery. 2011;12(4):50–53. Russian (Гвасалия Б.Р., Кочетов А.Г. Сравнительный анализ применения силиконовых уретральных катетеров с серебряным покрытием и без в профилактике нозокомиальных инфекций мочевыводящих путей. Андрология и генитальная хирургия. 2011;12(4):50–53).
  28. Takahashi S., Arakawa S., Ishikawa K. et al. Guidelines for Infection Control in the Urological Field, including Urinary Tract Management (revised second edition). Int J Urol. 2021;28(12):1198–1211. doi: 10.1111/iju.14684.
  29. Leitner L., Ujmajuridze A., Chanishvili N., Goderdzishvili M., Chkonia I., et al. Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: A randomised, placebo-controlled, double-blind clinical trial. Lancet Infect. Dis. 2021;21:427–436.
  30. Esipov A.S., Kochetov A.G., Alekhnovich A.V., Gvasalia B.R. and others. The use of nitrogen monoxide and lymphotropic therapy for the prevention of purulent-inflammatory postoperative complications in urology. Hospital medicine: science and practice. 2022;5(3):47–55. Russian (Есипов А.С., Кочетов А.Г., Алехнович А.В., Гвасалия Б.Р. и др. Использование монооксида азота и лимфотропной терапии для профилактики гнойно-воспалительных послеоперационных осложнений в урологии. Госпитальная медицина: наука и практика. 2022;5(3):47–55).
  31. Vasiliev A.O., Zaitsev A.V., Kalinina N.A., Shiryaev A.A., Kim Yu.A., Pushkar D.Yu. Bacteriophages in the treatment of lower urinary tract infections. Consilium Medicum. 2019;21(7):38–41. Russian (Васильев А.О., Зайцев А.В., Калинина Н.А., Ширяев А.А., Ким Ю.А., Пушкарь Д.Ю. Бактериофаги в лечении инфекций нижних мочевыводящих путей. Consilium Medicum. 2019;21(7):38–41).

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу
2. Fig. Comparison of the urine microbiome in normal and UTIs (adapted from S. Kenneally, 2022)

Жүктеу (479KB)
Метадеректер

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>